← International Flavors & Fragrances overview

International Flavors & Fragrances vs Element Solutions: why the prices moved differently

Weekly · monthly · quarterly news summaries, side by side in time

International Flavors & Fragrances Inc (IFF)

Q3 2026
▲3▼1

IFF's big portfolio overhaul and buyback drive the story

  • IFF sells Food Ingredients for $3.8B and launches $2.5B buyback IFF agreed to sell its Food Ingredients unit to CVC for about $3.8 billion and announced a $2.5 billion share buyback, including a $500 million accelerated repurchase. This shrinks the company but sharpens focus on higher-margin Taste, Scent, and Health & Biosciences, and returning cash supports the stock.

    This is the biggest strategic event of the period, reshaping IFF's business and capital returns.

  • Q2 results miss and guidance cut on stranded costs IFF's Q2 revenue fell 29% to $1.95 billion and missed estimates badly, while full-year guidance was cut to $7.5 billion. Management blamed temporary stranded costs from the divestiture, but the miss and lower outlook weigh on investor confidence.

    The earnings miss and guidance cut are the main negative counterweight to the positive portfolio moves.

  • New product launches in scent and animal nutrition IFF launched SENSORA pro-fragrance technology, Omni-Bos PHY enzyme for dairy cattle, and AQUASCENT water-based fragrance carrier. These innovations target higher-margin growth areas and support the company's focus on R&D-led differentiation.

    Product launches show IFF's innovation pipeline and support future revenue growth.

  • Analysts and value funds see IFF as undervalued Morgan Stanley and Argus raised price targets, and Heartland Mid Cap Value Fund called IFF a deep-value opportunity trading at a discount to Givaudan. The new buyback and portfolio streamlining are seen as catalysts to close the valuation gap.

    This reflects external validation of IFF's turnaround story and potential upside.

August 2026
▲3▼1

IFF's big portfolio overhaul and buyback drive the story

  • IFF sells Food Ingredients for $3.8B and launches $2.5B buyback IFF agreed to sell its Food Ingredients unit to CVC for about $3.8 billion and announced a $2.5 billion share buyback, including a $500 million accelerated repurchase. This shrinks the company but sharpens focus on higher-margin Taste, Scent, and Health & Biosciences, and returning cash supports the stock.

    This is the biggest strategic event of the period, reshaping IFF's business and capital returns.

  • Q2 results miss and guidance cut on stranded costs IFF's Q2 revenue fell 29% to $1.95 billion and missed estimates badly, while full-year guidance was cut to $7.5 billion. Management blamed temporary stranded costs from the divestiture, but the miss and lower outlook weigh on investor confidence.

    The earnings miss and guidance cut are the main negative counterweight to the positive portfolio moves.

  • New product launches in scent and animal nutrition IFF launched SENSORA pro-fragrance technology, Omni-Bos PHY enzyme for dairy cattle, and AQUASCENT water-based fragrance carrier. These innovations target higher-margin growth areas and support the company's focus on R&D-led differentiation.

    Product launches show IFF's innovation pipeline and support future revenue growth.

  • Analysts and value funds see IFF as undervalued Morgan Stanley and Argus raised price targets, and Heartland Mid Cap Value Fund called IFF a deep-value opportunity trading at a discount to Givaudan. The new buyback and portfolio streamlining are seen as catalysts to close the valuation gap.

    This reflects external validation of IFF's turnaround story and potential upside.

Latest
▲3▼1

IFF's big portfolio overhaul and buyback drive the story

  • IFF sells Food Ingredients for $3.8B and launches $2.5B buyback IFF agreed to sell its Food Ingredients unit to CVC for about $3.8 billion and announced a $2.5 billion share buyback, including a $500 million accelerated repurchase. This shrinks the company but sharpens focus on higher-margin Taste, Scent, and Health & Biosciences, and returning cash supports the stock.

    This is the biggest strategic event of the period, reshaping IFF's business and capital returns.

  • Q2 results miss and guidance cut on stranded costs IFF's Q2 revenue fell 29% to $1.95 billion and missed estimates badly, while full-year guidance was cut to $7.5 billion. Management blamed temporary stranded costs from the divestiture, but the miss and lower outlook weigh on investor confidence.

    The earnings miss and guidance cut are the main negative counterweight to the positive portfolio moves.

  • New product launches in scent and animal nutrition IFF launched SENSORA pro-fragrance technology, Omni-Bos PHY enzyme for dairy cattle, and AQUASCENT water-based fragrance carrier. These innovations target higher-margin growth areas and support the company's focus on R&D-led differentiation.

    Product launches show IFF's innovation pipeline and support future revenue growth.

  • Analysts and value funds see IFF as undervalued Morgan Stanley and Argus raised price targets, and Heartland Mid Cap Value Fund called IFF a deep-value opportunity trading at a discount to Givaudan. The new buyback and portfolio streamlining are seen as catalysts to close the valuation gap.

    This reflects external validation of IFF's turnaround story and potential upside.

Element Solutions Inc (ESI)

Q3 2026
▲3▼1

Element Solutions: Merger Scrapped, AI Demand Drives Stock

  • Solstice acquisition offer In July, Solstice agreed to buy Element Solutions for $14.5 billion, or $50.10 per share, a 15% premium. The news sent shares up 49.8% year-to-date, as investors anticipated a lucrative takeover.

    This was the biggest event of the quarter, initially driving the stock higher.

  • Merger terminated In August, the merger was mutually scrapped after shareholder pushback. The takeover premium vanished, along with $180 million in expected annual cost savings. No breakup fees were paid, but the stock lost its deal-driven support.

    The termination reversed the earlier gains and removed a major catalyst.

  • Strong earnings and AI demand Record Q2 sales of $977.9 million (up 56%) and raised EBITDA guidance showed robust business momentum. Goldman Sachs reinstated a Buy rating with a $44 target, citing AI and data-center demand for ESI's products.

    Fundamental strength and analyst optimism provided a positive counterweight after the deal fell through.

  • Legal uncertainty fades Deal-related board lawsuits largely faded with the merger's termination, removing a legal overhang. The company continued paying its $0.08 dividend, signaling stability.

    Reduced legal risk and steady dividend reinforced investor confidence.

August 2026
▲3▼1

ESI's Solstice merger called off; analysts back standalone AI-driven growth

  • Merger scrapped, no breakup fee Element and Solstice mutually ended their $14.5 billion merger after shareholder pushback, with no fees owed. The stock rose 4% after hours. Ending the deal removes uncertainty and lets Element stay independent, though it gives up the roughly $50 per share takeover premium and $180 million in yearly cost savings.

    The termination is the period's biggest event and directly resets what ESI is worth.

  • Goldman reinstates Buy, $44 target Goldman Sachs restarted coverage with a Buy rating and $44 price target, calling the merger's end a positive catalyst that removes risk and dilution. Analysts said AI infrastructure and data center buildouts drive strong demand, and Element's asset-light model captures high-margin AI growth faster than peers.

    A major analyst explicitly frames the merger exit as good news and names the growth engine.

  • Earnings beat and dividend kept Element reported quarterly EPS and revenue above expectations, lifting shares after hours. It also declared its regular $0.08 quarterly dividend, payable September 15. Steady profit and cash returned to shareholders support the stock while the company refocuses on its own operations.

    Shows the underlying business stayed solid through the merger drama.

  • Deal-era lawsuits fade with merger Law firms investigated whether Element's board got a fair price and met its duties in the Solstice sale, citing insider benefits and a stiff penalty for rival bids. Those claims were tied to the deal; with the merger now terminated, the main legal cloud has largely lifted.

    Explains the legal risk that hung over the stock and why it now matters less.

Latest
▲3▼1

ESI's Solstice merger called off; analysts back standalone AI-driven growth

  • Merger scrapped, no breakup fee Element and Solstice mutually ended their $14.5 billion merger after shareholder pushback, with no fees owed. The stock rose 4% after hours. Ending the deal removes uncertainty and lets Element stay independent, though it gives up the roughly $50 per share takeover premium and $180 million in yearly cost savings.

    The termination is the period's biggest event and directly resets what ESI is worth.

  • Goldman reinstates Buy, $44 target Goldman Sachs restarted coverage with a Buy rating and $44 price target, calling the merger's end a positive catalyst that removes risk and dilution. Analysts said AI infrastructure and data center buildouts drive strong demand, and Element's asset-light model captures high-margin AI growth faster than peers.

    A major analyst explicitly frames the merger exit as good news and names the growth engine.

  • Earnings beat and dividend kept Element reported quarterly EPS and revenue above expectations, lifting shares after hours. It also declared its regular $0.08 quarterly dividend, payable September 15. Steady profit and cash returned to shareholders support the stock while the company refocuses on its own operations.

    Shows the underlying business stayed solid through the merger drama.

  • Deal-era lawsuits fade with merger Law firms investigated whether Element's board got a fair price and met its duties in the Solstice sale, citing insider benefits and a stiff penalty for rival bids. Those claims were tied to the deal; with the merger now terminated, the main legal cloud has largely lifted.

    Explains the legal risk that hung over the stock and why it now matters less.

July 2026
▲4

Solstice's $14.5B buyout and record Q2 results drive ESI

  • Solstice to acquire ESI at a 15% premium Solstice Advanced Materials agreed to buy Element Solutions for $14.5 billion, or about $50.10 per share, a 15% premium. ESI holders get $10 cash plus 0.5 Solstice shares per share. This locks in a higher value for ESI and supports the stock price.

    The acquisition is the main event setting a floor and premium for ESI shares.

  • Record Q2 sales and raised 2026 profit outlook ESI reported record Q2 net sales of $977.9 million, up 56%, with profit rising to $77.3 million. Electronics revenue jumped 75% on AI data center and semiconductor demand. Management raised full-year 2026 adjusted EBITDA guidance to $690–710 million, signaling confidence.

    Strong results and higher guidance show the business is performing well, supporting the stock.

  • Q2 earnings beat estimates, stock up 49.8% YTD ESI beat Q2 earnings and revenue estimates, with adjusted EPS of $0.47 versus $0.43 expected. Revenue topped consensus by 11.5%. The company has now beaten estimates for four straight quarters. Shares have gained about 49.8% this year, far outpacing the S&P 500.

    Consistent beats and strong stock performance reinforce positive momentum.

  • Solstice raises 2026 guidance, cites ESI deal Solstice, the buyer, reported strong Q2 sales of $1.15 billion and raised its full-year 2026 outlook. Its CEO highlighted the pending ESI acquisition as key to building an advanced materials platform with more electronics and AI exposure. A healthier buyer reduces deal risk.

    A financially strong acquirer makes the pending merger more likely to close smoothly.

▲4

Solstice's $14.5B buyout and record Q2 results drive ESI

  • Solstice to acquire ESI at a 15% premium Solstice Advanced Materials agreed to buy Element Solutions for $14.5 billion, or about $50.10 per share, a 15% premium. ESI holders get $10 cash plus 0.5 Solstice shares per share. This locks in a higher value for ESI and supports the stock price.

    The acquisition is the main event setting a floor and premium for ESI shares.

  • Record Q2 sales and raised 2026 profit outlook ESI reported record Q2 net sales of $977.9 million, up 56%, with profit rising to $77.3 million. Electronics revenue jumped 75% on AI data center and semiconductor demand. Management raised full-year 2026 adjusted EBITDA guidance to $690–710 million, signaling confidence.

    Strong results and higher guidance show the business is performing well, supporting the stock.

  • Q2 earnings beat estimates, stock up 49.8% YTD ESI beat Q2 earnings and revenue estimates, with adjusted EPS of $0.47 versus $0.43 expected. Revenue topped consensus by 11.5%. The company has now beaten estimates for four straight quarters. Shares have gained about 49.8% this year, far outpacing the S&P 500.

    Consistent beats and strong stock performance reinforce positive momentum.

  • Solstice raises 2026 guidance, cites ESI deal Solstice, the buyer, reported strong Q2 sales of $1.15 billion and raised its full-year 2026 outlook. Its CEO highlighted the pending ESI acquisition as key to building an advanced materials platform with more electronics and AI exposure. A healthier buyer reduces deal risk.

    A financially strong acquirer makes the pending merger more likely to close smoothly.